Cardinal Health Likely To Post Higher Q4 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Cardinal Health, Inc. CAH is expected to report its fourth-quarter financial results, before the opening bell on Aug. 15, 2023.

Analysts expect the company to post quarterly earnings at $1.49 per share, up from year-ago earnings of $1.05 per share. The company’s revenue might come in at $52.72 billion, compared to $47.1 billion in the year-ago period.

Cardinal Health shares gained 0.7% to close at $92.99 on Monday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • Mizuho analyst Ann Hynes maintained a Neutral rating and raised the price target from $85 to $94 on July 11, 2023. This analyst has an accuracy rate of 72%.
  • UBS analyst Kevin Caliendo maintained a Buy and increased the price target from $93 to $97 on June 12, 2023. This analyst has an accuracy rate of 73%.
  • JP Morgan analyst Lisa Gill maintained a Neutral rating and boosted the price target from $90 to $93 on June 9, 2023. This analyst has an accuracy rate of 63%.
  • Morgan Stanley analyst Erin Wright maintained an Overweight rating and increased the price target from $86 to $90 on Feb. 3, 2023. This analyst has an accuracy rate of 77%.
  • Credit Suisse analyst A.J. Rice maintained a Neutral rating and raised the price target from $64 to $79 on Nov. 22, 2022. This analyst has an accuracy rate of 74%.

Read This Next: Quince Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPrice TargetPre-Market OutlookMarketsAnalyst RatingsTrading IdeasExpert IdeasMost Accurate Analysts
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...